Cirdan Imaging Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cirdan Imaging Ltd. - overview
Established
2010
Location
Lisburn, Northern Ireland, UK
Primary Industry
Healthcare IT
About
Cirdan Imaging Ltd. , based in the UK, specializes in innovative laboratory informatics software and imaging solutions aimed at enhancing diagnostic workflows and patient care. Founded in 2010 and headquartered in Lisburn, UK, Cirdan Imaging Ltd. focuses on providing advanced laboratory solutions.
In April 2026, Cirdan Imaging Ltd. raised approximately GBP 7 million in equity and debt funding from Salica Investments, 57 Stars, and Clarendon Fund Managers. Hugh Cormican serves as the CEO of the company. Cirdan Imaging Ltd.
provides cutting-edge laboratory informatics software and imaging solutions, including the ULTRA Laboratory Information System (LIS), which enhances laboratory data management through a cloud-first approach, and Cirdan Tutor, an educational platform for pathologists. The company also offers specialized imaging products like the Solas OR XL and Core Lite, designed for pathology labs, and operates in international markets such as North America, Europe, and Australia, catering to hospitals, research institutions, and national laboratories. In the most recent fiscal year 2024, Cirdan generated revenue of GBP 10,435,493. 90, with an EBITDA of GBP 102,027.
70, reflecting the company’s robust financial performance through its direct sales and subscription models. The company will use the April 2026 funding to support the continued development and global deployment of Vision Path and to accelerate international expansion.
Current Investors
Kernel Capital, Clarendon Fund Managers, 57 Stars
Primary Industry
Healthcare IT
Sub Industries
Bioinformatics, Healthcare IT, Oncology/Cancer Treatment
Website
www.cirdan.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Cirdan Imaging Ltd. - timeline of key events
Cirdan Imaging Ltd. - financials
| Fiscal Year Ended | Jun 30, 2014 | Jun 30, 2015 | Jun 30, 2016 | Jun 30, 2017 | Jun 30, 2018 | Jun 30, 2019 | Jun 30, 2020 | Jun 30, 2021 | Jun 30, 2022 | Jun 30, 2023 | Jun 30, 2024 | Jun 30, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 2,815,807 | 3,105,494 | - | - | 2,874,816 | 4,005,815 | 4,505,318 | 5,201,697 | 5,092,169 | - | - | - |
| % Revenue Growth (YoY) | - | 10.3% | - | - | - | 39.3% | 12.5% | 15.5% | (2.1%) | - | - | - |
| EBITDA (USD) | 178,949 | 343,810 | - | - | (756,982) | (1,067,206) | (2,040,041) | (1,397,889) | (981,067) | - | - | - |
| Operating Income (USD) | 21,049 | 66,522 | - | - | (956,453) | (1,278,085) | (2,188,608) | (1,676,665) | (1,297,839) | - | - | - |
| Operating Margin | 0.7% | 2.1% | - | - | (33.3%) | (31.9%) | (48.6%) | (32.2%) | (25.5%) | - | - | - |
| % EBITDA Margin | 6.4% | 11.1% | - | - | (26.3%) | (26.6%) | (45.3%) | (26.9%) | (19.3%) | - | - | - |
| NET Income (USD) | (1,660) | 26,945 | - | (162,775) | (501,143) | (1,009,396) | (1,996,505) | (930,023) | (1,587,308) | - | - | - |
| % Net Margin | (0.1%) | 0.9% | - | - | (17.4%) | (25.2%) | (44.3%) | (17.9%) | (31.2%) | - | - | - |
Cirdan Imaging Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.